ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

NFX Nuformix Plc

0.047
-0.0005 (-1.05%)
22 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Nuformix Plc LSE:NFX London Ordinary Share GB00BYW79Y38 ORD 0.05P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.0005 -1.05% 0.047 0.044 0.05 - 6,031,551 16:35:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -859k -0.0010 -0.50 389.17k
Nuformix Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker NFX. The last closing price for Nuformix was 0.05p. Over the last year, Nuformix shares have traded in a share price range of 0.04p to 0.44p.

Nuformix currently has 819,309,368 shares in issue. The market capitalisation of Nuformix is £389,171.95 . Nuformix has a price to earnings ratio (PE ratio) of -0.50.

Nuformix Share Discussion Threads

Showing 9351 to 9373 of 9625 messages
Chat Pages: 385  384  383  382  381  380  379  378  377  376  375  374  Older
DateSubjectAuthorDiscuss
28/11/2023
19:49
Depends on your point of view
for fx sake
28/11/2023
11:16
Dan keeping his head down , will it be good or bad .
jotoha2
16/11/2023
22:34
The sack is empty...Santa already sold the goodies off
for fx sake
16/11/2023
17:28
Why the 25% spread at these levels,aren't they supposed to make a market not suppress one.,
peverill
16/11/2023
14:53
Clearly something is going on , up or down
jotoha2
16/11/2023
07:57
Indeed. Fingers need to be pulled out
for fx sake
15/11/2023
11:17
Yes in for long time to come old chap,
markstevenkirby80
14/11/2023
18:00
We staying
for fx sake
31/10/2023
15:15
All seems to have gone very quiet since they got their money for 'discharging the responsibility for maintaining the upkeep costs of the patent estate' for NXP001.
for fx sake
26/10/2023
13:54
Maybe maybe GSK
jotoha2
04/10/2023
17:50
Windfall eh?Anyone know how to make cider out of peanuts?
for fx sake
04/10/2023
09:24
https://www.proactiveinvestors.co.uk/companies/news/1028626/nuformix-to-fund-its-unlicensed-programs-with-nxp001-windfall-1028626.html
peverill
22/9/2023
10:45
LOL! When was the last time you saw real volume bought?
for fx sake
22/9/2023
10:22
I'm talking real volume, not 2 grands worth.
the imperialist
22/9/2023
10:15
Looks like someone bought over a million shares without too much trouble
for fx sake
22/9/2023
08:12
Interesting that you can sell in volume, but can't get a buy quote for even a small amount. Is there any news imminent?
the imperialist
19/9/2023
12:21
Probably at a stage now where it is no longer if but when.For a company to want to buy the IP rather than license it,speaks volumes for the tech.Talks also on going on both 002 and 004,a first mention for talks on 004,great news.
peverill
19/9/2023
07:28
Clearly Dan beliefs he has a clear sight in coming up with a mega contract , time will tell if he has it in him .
jotoha2
19/9/2023
06:16
The net positive impact on our cash position will better enable the Company to progress our core NXP002 and NXP004 programmes and respond to requests for additional data as we continue partnering interactions for these programmes."
peverill
18/9/2023
14:19
Why don't you try reading it?"Under the revised agreement with, Oxilio will acquire ownership of Nuformix's NXP001 patent estate, with Nuformix receiving the additional milestone payments referred to above, whilst retaining further development milestones and royalties capped at GBP2 million per year."The keywords there are 'whilst retaining'. Meaning no change to existing capped royalties at 2m per year. The royalties will not be paid until the product goes to market and that will be years away. What's more, we have no idea how much revenue Oxilio has to make in order to pay us 2m. It might require 2bn a year, for all we know.The only thing of interest is the milestones we receive for the patent and only Oxilio and the NFX board know what they are worth. Alarm bells should ringing as to why they refuse to disclose them.
for fx sake
18/9/2023
13:55
You'd have thought the bashers would have read the RNS!
the imperialist
18/9/2023
13:54
That 2 million is the capped MAXIMUM royalties that we could ever expect per annum if Oxilio sales were to meet whatever (undisclosed) levels that were agreed. That was agreed before we gave the asset ownershio away for whatever (undisclosed) milestones are being offered in return now.
for fx sake
18/9/2023
13:53
Receiving Royalties of up to two million a year
leadersoffice
Chat Pages: 385  384  383  382  381  380  379  378  377  376  375  374  Older

Your Recent History

Delayed Upgrade Clock